Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

13 results
Display

Response: Obesity Markers as Predictors for Colorectal Neoplasia (J Obes Metab Syndr 2017;26:28-35)

Kwon JH, Ko HJ, Youn CH, Choi HI

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):153-154.
  • doi: 10.7570/jomes.2017.26.2.153
No abstract available.
Letter to the Editor: Obesity Markers as Predictors for Colorectal Neoplasia (J Obes Metab Syndr 2017;26:28-35)

Kim JY

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):151-152.
  • doi: 10.7570/jomes.2017.26.2.151
No abstract available.
A Case of Fulminant Type 1 Diabetes in a Patient with Type 2 Diabetes Mellitus

Kim JM, Han JH, Joung KH, Lee JH, Kim HJ, Ku BJ

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):147-150.
  • doi: 10.7570/jomes.2017.26.2.147
Fulminant type 1 diabetes mellitus is a recently identified subtype of type 1 diabetes characterized by abrupt disease onset, a very short (
Agreement Between Actual and Perceived Body Weight in Adolescents and Their Weight Control Behaviors

Shin SM

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):138-146.
  • doi: 10.7570/jomes.2017.26.2.138
BACKGROUND: To investigate the agreements between actual and perceived body weight status among adolescents and to identify the associations of disagreements with their weight control behaviors. METHODS: This study used the...
Prevalence and Associated Characteristics of Metabolically Healthy Obese Phenotypes in a Community Dwelling Population

Shin S, Kim JM, Sung S, Kim HS

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):130-137.
  • doi: 10.7570/jomes.2017.26.2.130
BACKGROUND: Recent research has focused on overweight and obese individuals with healthy metabolic profiles. Metabolically healthy and obese (MHO) individuals may have unique characteristics, compared to metabolically unhealthy obese (MUO)...
Development and Cross-Validation of Equation for Estimating Percent Body Fat of Korean Adults According to Body Mass Index

Sung H, Mun J

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):122-129.
  • doi: 10.7570/jomes.2017.26.2.122
BACKGROUND: Using BMI as an independent variable is the easiest way to estimate percent body fat. Thus far, few studies have investigated the development and cross-validation of an equation for...
Metabolic Syndrome is Associated with Lower Plasma Levels of Desacyl Ghrelin and Total Ghrelin in Asymptomatic Middle-aged Korean Men

Cho YH, Lee SY, Jeong DW, Cho AR, Jeon JS, Kim YJ, Lee JG, Yi YH, Tak YJ, Hwang HR, Lee SH, Lee SM

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):114-121.
  • doi: 10.7570/jomes.2017.26.2.114
BACKGROUND: Desacyl ghrelin is acylated by ghrelin O-acyltransferase (GOAT) and converted to acyl ghrelin. To date, little is known about the relationship among the levels of these two forms of...
Efficacy of Body Weight Reduction on the SGLT2 Inhibitor in People with Type 2 Diabetes Mellitus

Cho HA, Jung YL, Lee YH, Lee YC, Lee JE, Lee SJ, Jeong SJ, Kim CH

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):107-113.
  • doi: 10.7570/jomes.2017.26.2.107
BACKGROUND: Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces hyperglycemia and body weight by inhibiting renal glucose reabsorption. However, only a few studies have demonstrated efficacy of dapagliflozin for type 2 diabetic...
Does Weight Gain Associated with Thiazolidinedione Use Negatively Affect Cardiometabolic Health?

Ko KD, Kim KK, Lee KR

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):102-106.
  • doi: 10.7570/jomes.2017.26.2.102
Thiazolidinediones (TZDs) are oral anti-diabetic drugs that are peroxisome proliferator-activated receptor gamma (PPARγ) agonists and act as insulin sensitizers. The clinical efficacy and durability of the currently available TZDs in...
Revisional Bariatric Surgery: Focus on Quality of Life

Chew CA, Shabbir A

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):97-101.
  • doi: 10.7570/jomes.2017.26.2.97
Bariatric surgery is considered to be the most effective treatment for morbid obesity. At present, revisional surgery is considered in patients who experience complications, or in whom the intended weight...
The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease

Miura K, Ishioka M, Iijima K

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):86-96.
  • doi: 10.7570/jomes.2017.26.2.86
Obesity is characterized by low-grade chronic inflammation and is closely associated with the cardiovascular diseases, diabetes, and nonalcoholic fatty liver disease. Emerging data demonstrate that the gut microbiota contributes to...
Sleep and Obesity in Childhood

Lee JE

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):84-85.
  • doi: 10.7570/jomes.2017.26.2.84
No abstract available.
Journal of Obesity & Metabolic Syndrome: A New International Journal Targeting the Pathophysiology and Treatment of Obesity and Metabolic Syndrome

Lim S

  • J Obes Metab Syndr.
  • 2017 Jun;26(2):81-83.
  • doi: 10.7570/jomes.2017.26.2.81
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr